HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Nakamura Selected Research

Miliaria (Prickly Heat)

12/2022Enfortumab vedotin-induced cutaneous adverse events manifesting as miliaria-like eruptions with the presence of keratinocyte apoptosis in clinically intact skin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Nakamura Research Topics

Disease

106Neoplasms (Cancer)
02/2021 - 01/2000
28Carcinogenesis
08/2013 - 01/2000
23Breast Neoplasms (Breast Cancer)
08/2014 - 01/2000
21Infections
12/2020 - 01/2000
16Colorectal Neoplasms (Colorectal Cancer)
11/2014 - 03/2000
15Inflammation (Inflammations)
01/2020 - 01/2000
14Carcinoma (Carcinomatosis)
03/2019 - 01/2000
12Hepatocellular Carcinoma (Hepatoma)
03/2012 - 01/2000
11Neoplasm Metastasis (Metastasis)
01/2022 - 01/2000
11Hypertension (High Blood Pressure)
10/2018 - 05/2000
11Colonic Neoplasms (Colon Cancer)
02/2007 - 03/2000
10Type 2 Diabetes Mellitus (MODY)
05/2017 - 08/2000
10Asthma (Bronchial Asthma)
01/2016 - 01/2000
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2021 - 01/2000
9Necrosis
01/2017 - 07/2000
9Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
11/2014 - 01/2000
8Neuroblastoma
12/2016 - 10/2000
7Lung Neoplasms (Lung Cancer)
12/2019 - 11/2000
7Stomach Neoplasms (Stomach Cancer)
03/2013 - 04/2000
7Prostatic Neoplasms (Prostate Cancer)
01/2013 - 01/2001
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2017 - 04/2000
6Hemorrhage
05/2016 - 07/2001
6Fibrosis (Cirrhosis)
04/2015 - 05/2001
6Adenocarcinoma
06/2013 - 01/2000
6Body Weight (Weight, Body)
09/2002 - 02/2000
6Leukemia
09/2001 - 06/2000
5Adenoma (Adenomas)
01/2016 - 10/2000
5Seasonal Allergic Rhinitis (Hay Fever)
03/2015 - 02/2000
5Allergic Rhinitis
03/2015 - 01/2000
5Wounds and Injuries (Trauma)
09/2014 - 05/2001
5Pain (Aches)
11/2008 - 09/2001
5Edema (Dropsy)
05/2001 - 01/2000
5Cataract (Cataracts)
04/2001 - 05/2000
4Melanoma (Melanoma, Malignant)
01/2022 - 11/2019
4Lymphatic Metastasis
03/2019 - 01/2006
4Esophageal Neoplasms (Esophageal Cancer)
03/2019 - 02/2000
4Cysts
09/2017 - 01/2001
4Diabetes Mellitus
05/2017 - 04/2000
4Osteoporosis
01/2017 - 03/2010
4Neutropenia
07/2015 - 12/2001
4Fever (Fevers)
06/2009 - 07/2000
4Myocardial Infarction
08/2005 - 01/2001
4Rheumatoid Arthritis
05/2005 - 03/2000
4Hypothermia
09/2002 - 09/2000
3Hemangiosarcoma (Angiosarcoma)
11/2020 - 12/2010
3Atherosclerosis
01/2020 - 08/2006

Drug/Important Bio-Agent (IBA)

37Proteins (Proteins, Gene)FDA Link
01/2017 - 01/2000
20DNA (Deoxyribonucleic Acid)IBA
02/2013 - 02/2000
17CytokinesIBA
01/2019 - 01/2000
17Messenger RNA (mRNA)IBA
05/2014 - 01/2000
16Complementary DNA (cDNA)IBA
01/2011 - 02/2000
15Biological ProductsIBA
05/2014 - 01/2000
15beta CateninIBA
11/2001 - 01/2000
9Pharmaceutical PreparationsIBA
01/2017 - 02/2000
9AntibodiesIBA
12/2014 - 02/2000
8Biomarkers (Surrogate Marker)IBA
02/2021 - 04/2000
8Glucose (Dextrose)FDA LinkGeneric
10/2018 - 11/2000
8AndrogensIBA
01/2013 - 08/2000
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2005 - 02/2000
7EnzymesIBA
12/2018 - 08/2000
7Cisplatin (Platino)FDA LinkGeneric
07/2015 - 03/2000
7AllergensIBA
03/2015 - 01/2000
7Indicators and Reagents (Reagents)IBA
04/2008 - 03/2000
6InterleukinsIBA
01/2019 - 01/2000
6Estrogen ReceptorsIBA
02/2014 - 03/2000
6RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
08/2007 - 01/2000
5Doxorubicin (Adriamycin)FDA LinkGeneric
11/2020 - 03/2000
5CholesterolIBA
01/2020 - 11/2000
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2019 - 06/2000
5Docetaxel (Taxotere)FDA Link
07/2015 - 03/2000
5Small Interfering RNA (siRNA)IBA
11/2014 - 09/2007
5Peptides (Polypeptides)IBA
07/2014 - 06/2000
5Irinotecan (Camptosar)FDA LinkGeneric
05/2006 - 07/2001
5Oxygen (Dioxygen)IBA
03/2006 - 01/2000
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2017 - 06/2000
4AntigensIBA
01/2017 - 06/2001
4Histones (Histone)IBA
12/2013 - 04/2008
4ParaffinIBA
06/2013 - 01/2000
4AlbuminsIBA
09/2012 - 03/2001
4SteroidsIBA
03/2012 - 08/2001
4Transcription Factors (Transcription Factor)IBA
01/2012 - 01/2000
4Ethanol (Ethyl Alcohol)IBA
02/2007 - 12/2000
4Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
06/2005 - 12/2000
4Triglycerides (Triacylglycerol)IBA
09/2002 - 02/2000
4AntioxidantsIBA
11/2001 - 05/2000
4Fluorouracil (Carac)FDA LinkGeneric
10/2001 - 03/2000
4Free RadicalsIBA
09/2000 - 01/2000
3LigandsIBA
11/2019 - 01/2012
3Carcinoembryonic AntigenIBA
01/2019 - 12/2000
3LipidsIBA
10/2018 - 02/2000

Therapy/Procedure

47Therapeutics
12/2021 - 02/2000
20Drug Therapy (Chemotherapy)
01/2021 - 02/2000
13Transplantation
10/2018 - 08/2000
8Radiotherapy
01/2021 - 09/2000
7Liver Transplantation
04/2015 - 11/2000
5Immunotherapy
12/2021 - 10/2001
5Kidney Transplantation
10/2018 - 09/2008
5Adjuvant Chemotherapy
09/2001 - 03/2000
4Coronary Artery Bypass (Coronary Artery Bypass Surgery)
11/2009 - 01/2001
4Lasers (Laser)
01/2003 - 05/2001